These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9292816)

  • 1. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C.
    Makino Y; Tanaka H; Nakamura K; Fujita M; Akiyama K; Makino I
    J Rheumatol; 1994 Sep; 21(9):1771-2. PubMed ID: 7799367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
    Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
    Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
    Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
    Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
    Wilson LE; Widman D; Dikman SH; Gorevic PD
    Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.
    Höftberger R; Garzuly F; Dienes HP; Grubits J; Rohonyi B; Fischer G; Hanzely Z; Lassmann H; Budka H
    Mult Scler; 2007 Nov; 13(9):1100-6. PubMed ID: 17967838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbation of antiliver cytosol antibody-positive autoimmune chronic hepatitis by alpha-interferon.
    Gschwantler M; Schrutka-Kölbl C; Weiss W
    Am J Gastroenterol; 1995 Dec; 90(12):2239-40. PubMed ID: 8540531
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
    Demirturk N; Cevik F; Demirdal T; Aykin N; Aslan V
    Platelets; 2006 Aug; 17(5):340-3. PubMed ID: 16928608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis.
    Reinhold-Keller E; Lamprecht P; Feller AC; Gross WL
    Clin Exp Rheumatol; 2001; 19(2):227-8. PubMed ID: 11326494
    [No Abstract]   [Full Text] [Related]  

  • 16. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-induced sarcoidosis.
    Doyle MK; Berggren R; Magnus JH
    J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid disorders associated with interferon treatment in patients with chronic viral hepatitis or multiple sclerosis].
    Diago JI; del Olmo D; Alcázar V; Martínez de Icaya P; Rodríguez E; Martínez Montiel P
    Med Clin (Barc); 1999 Jun; 113(2):50-1. PubMed ID: 10425619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
    Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
    An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
    Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.